GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » PEG Ratio

RNUGF (ReNeuron Group) PEG Ratio : N/A (As of Jun. 25, 2025)


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ReNeuron Group's PE Ratio without NRI is 0.00. ReNeuron Group's 5-Year EBITDA growth rate is 0.00%. Therefore, ReNeuron Group's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for ReNeuron Group's PEG Ratio or its related term are showing as below:



RNUGF's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.93
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


ReNeuron Group PEG Ratio Historical Data

The historical data trend for ReNeuron Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group PEG Ratio Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ReNeuron Group's PEG Ratio

For the Biotechnology subindustry, ReNeuron Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's PEG Ratio falls into.


;
;

ReNeuron Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

ReNeuron Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


ReNeuron Group  (OTCPK:RNUGF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


ReNeuron Group PEG Ratio Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group Business Description

Traded in Other Exchanges
N/A
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group Headlines

From GuruFocus

ReNeuron Signs New Exosome Research Collaboration

By PRNewswire PRNewswire 06-25-2020

Edison Issues Outlook on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 08-26-2020

ReNeuron Expands Exosome IP Portfolio with Key Patent Grants

By PRNewswire PRNewswire 07-16-2019

Edison Issues Update on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 07-06-2020

ReNeuron Announces CTX Cell Line Shows Further Potential

By PRNewswire PRNewswire 05-07-2020

Full Year 2020 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024

ReNeuron Group (RENE): Extension Trial to Produce Data in Q122

By ACCESSWIRE ACCESSWIRE 10-11-2021